NL7202326A - - Google Patents
Info
- Publication number
- NL7202326A NL7202326A NL7202326A NL7202326A NL7202326A NL 7202326 A NL7202326 A NL 7202326A NL 7202326 A NL7202326 A NL 7202326A NL 7202326 A NL7202326 A NL 7202326A NL 7202326 A NL7202326 A NL 7202326A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH257871A CH548364A (de) | 1971-02-23 | 1971-02-23 | Verfahren zur herstellung neuer 9-(2-hydroxy-3-aminopropyl-9,10-dihydro-9,10-aethanoanthracene. |
CH66972A CH561685A5 (en) | 1972-01-17 | 1972-01-17 | Substd 9-(2-hydroxy-3-aminoprop-1-enyl) -9,10-dihydro-9,10-ethano - anthracenes - antidepressants |
AT335873A AT323726B (de) | 1971-02-23 | 1972-02-22 | Verfahren zur herstellung neuen 9-(2-hydroxy-3-aminopropyl-9,10-dihydro-9,10-äthanoanthracene |
Publications (3)
Publication Number | Publication Date |
---|---|
NL7202326A true NL7202326A (da) | 1972-08-25 |
NL174826B NL174826B (nl) | 1984-03-16 |
NL174826C NL174826C (nl) | 1984-08-16 |
Family
ID=32329363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL7202326A NL174826C (nl) | 1971-02-23 | 1972-02-22 | Werkwijze voor het bereiden van farmaceutische preparaten met een remmende werking op het centrale zenuwstelsel alsmede werkwijze voor het bereiden van voor toepassing in dergelijke preparaten geschikte 9-(3-(gesubstitueerd amino)-propyl) -9,10-dihydro-9,10-ethanoantraceenverbindingen. |
Country Status (17)
Country | Link |
---|---|
JP (1) | JPS5817740B1 (da) |
AR (5) | AR204070A1 (da) |
AU (1) | AU476863B2 (da) |
BE (1) | BE779665A (da) |
CA (1) | CA993892A (da) |
DE (1) | DE2207097C2 (da) |
DK (1) | DK141508B (da) |
ES (1) | ES400022A1 (da) |
FR (1) | FR2126353B1 (da) |
GB (1) | GB1378241A (da) |
HK (1) | HK61377A (da) |
HU (1) | HU164585B (da) |
KE (1) | KE2795A (da) |
MY (1) | MY7800117A (da) |
NL (1) | NL174826C (da) |
SE (1) | SE387110B (da) |
YU (6) | YU36288B (da) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE674185A (da) * | 1961-10-10 | |||
US3706765A (en) * | 1969-01-03 | 1972-12-19 | Ciba Geigy Corp | Hydroxyethano-anthracenes |
BE759571A (fr) * | 1969-11-28 | 1971-05-27 | Ciba Geigy | Nouvelles amines et procede pour leur preparation |
-
1972
- 1972-01-01 AR AR24066872A patent/AR204070A1/es active
- 1972-02-14 CA CA134,595A patent/CA993892A/en not_active Expired
- 1972-02-16 DE DE19722207097 patent/DE2207097C2/de not_active Expired
- 1972-02-18 SE SE199472A patent/SE387110B/xx unknown
- 1972-02-21 ES ES400022A patent/ES400022A1/es not_active Expired
- 1972-02-21 YU YU43172A patent/YU36288B/xx unknown
- 1972-02-21 AU AU39174/72A patent/AU476863B2/en not_active Expired
- 1972-02-22 GB GB814172A patent/GB1378241A/en not_active Expired
- 1972-02-22 BE BE779665A patent/BE779665A/xx not_active IP Right Cessation
- 1972-02-22 HU HUCI001211 patent/HU164585B/hu unknown
- 1972-02-22 NL NL7202326A patent/NL174826C/xx not_active IP Right Cessation
- 1972-02-22 DK DK81872A patent/DK141508B/da not_active IP Right Cessation
- 1972-02-23 FR FR7206115A patent/FR2126353B1/fr not_active Expired
- 1972-02-23 JP JP1816672A patent/JPS5817740B1/ja active Granted
-
1973
- 1973-01-01 AR AR24656873A patent/AR204309A1/es active
- 1973-02-19 AR AR24665873A patent/AR202178A1/es active
- 1973-02-19 AR AR24665773A patent/AR201551A1/es active
- 1973-11-19 AR AR15206373A patent/AR202284A1/es active
-
1977
- 1977-11-15 KE KE279577A patent/KE2795A/xx unknown
- 1977-12-08 HK HK61377A patent/HK61377A/xx unknown
-
1978
- 1978-12-30 MY MY7800117A patent/MY7800117A/xx unknown
-
1979
- 1979-06-18 YU YU143079A patent/YU40752B/xx unknown
- 1979-06-18 YU YU143179A patent/YU41867B/xx unknown
- 1979-06-18 YU YU142979A patent/YU40843B/xx unknown
- 1979-06-18 YU YU143279A patent/YU41642B/xx unknown
-
1980
- 1980-05-12 YU YU126180A patent/YU36363B/xx unknown
Also Published As
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
V4 | Lapsed because of reaching the maxim lifetime of a patent |